Cargando…

Evaluating the neuroprotective impact of senolytic drugs on human vision

Glaucoma, a chronic neurodegenerative disease of retinal ganglion cells (RGCs), is a leading cause of irreversible blindness worldwide. Its management currently focuses on lowering intraocular pressure to slow disease progression. However, disease-modifying, neuroprotective treatments for glaucoma r...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Nimri, Nevin W., Moore, Spencer M., Zangwill, Linda M., Proudfoot, James A., Weinreb, Robert N., Skowronska-Krawczyk, Dorota, Baxter, Sally L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730173/ https://www.ncbi.nlm.nih.gov/pubmed/33303874 http://dx.doi.org/10.1038/s41598-020-78802-4

Ejemplares similares

Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Maximova, Alexandra, et al.
Publicado: (2021)

Comparison of Optic Disc Ovality Index and Rotation Angle Measurements in Myopic Eyes Using Photography and OCT Based Techniques
por: Rezapour, Jasmin, et al.
Publicado: (2022)

Strategies for senolytic drug discovery
por: Power, Helen, et al.
Publicado: (2023)

Targeting of the NRL Pathway as a Therapeutic Strategy to Treat Retinitis Pigmentosa
por: Moore, Spencer M., et al.
Publicado: (2020)

Senolytic drugs: from discovery to translation
por: Kirkland, J. L., et al.
Publicado: (2020)

SENOLYTIC DRUGS: DISCOVERY, TRANSLATION, AND APPLICATION
por: LeBrasseur, Nathan
Publicado: (2019)

Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)

Relative Stability of Regional Facial and Ocular Temperature Measurements in Healthy Individuals
por: Micheletti, Eleonora, et al.
Publicado: (2022)

Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
por: Edwards, Genea, et al.
Publicado: (2020)

Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
por: Baxter, Sally L., et al.
Publicado: (2020)

Impact of senolytic treatment on immunity, aging, and disease
por: Lorenzo, Erica C., et al.
Publicado: (2023)

Senolytic therapy is neuroprotective and improves functional outcome long-term after traumatic brain injury in mice
por: Wang, Jing, et al.
Publicado: (2023)

Effects of senolytic drugs on human mesenchymal stromal cells
por: Grezella, Clara, et al.
Publicado: (2018)

Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy
por: Nogueira-Recalde, Uxía, et al.
Publicado: (2019)

Aging, Senescent Cells, and Senolytic Drugs: The Path to Translation
por: Kirkland, James
Publicado: (2020)

Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
por: Kudlova, Natalie, et al.
Publicado: (2022)

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
por: Zhu, Yi, et al.
Publicado: (2015)

Assessing Usability of Smartwatch Digital Health Devices for Home Blood Pressure Monitoring among Glaucoma Patients
por: Bhanvadia, Sonali B., et al.
Publicado: (2022)

Impact of Senolytic Treatment on Gene Expression in Aged Lung
por: Cho, Soo Jung, et al.
Publicado: (2023)

A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
por: Samaraweera, Leleesha, et al.
Publicado: (2017)

Targeting anxiety and senescence with senolytics
por: Raffaele, Marco, et al.
Publicado: (2022)

Senolytics in the treatment of diabetic retinopathy
por: Hassan, Jannah Waled, et al.
Publicado: (2022)

Therapeutic Potential of Senolytics in Cardiovascular Disease
por: Dookun, Emily, et al.
Publicado: (2020)

Discovery of senolytics using machine learning
por: Smer-Barreto, Vanessa, et al.
Publicado: (2023)

From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
por: L'Hôte, Valentin, et al.
Publicado: (2022)

Senolytics improve muscle adaptation in old mice
por: Dungan, Cory M., et al.
Publicado: (2023)

Senolytics and senostatics as adjuvant tumour therapy
por: Short, Susan, et al.
Publicado: (2019)

Cardiac glycosides are broad-spectrum senolytics
por: Guerrero, Ana, et al.
Publicado: (2019)

Galactose‐modified duocarmycin prodrugs as senolytics
por: Guerrero, Ana, et al.
Publicado: (2020)

NAD(+), Senolytics, or Pyruvate for Healthy Aging?
por: Zhou, Fang-Qiang
Publicado: (2021)

Senolytics in a Model of Alzheimer's Disease
por: Wang, Ellen, et al.
Publicado: (2021)

Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)

Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
por: Rocha, Lorena Raquel, et al.
Publicado: (2019)

ELOVL2: Not just a biomarker of aging
por: Chao, Daniel L., et al.
Publicado: (2020)

Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Triana-Martínez, Francisco, et al.
Publicado: (2019)

Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Lim, Songhyun, et al.
Publicado: (2021)

Anti-aging: senolytics or gerostatics (unconventional view)
por: Blagosklonny, Mikhail V.
Publicado: (2021)

Senolytics: Potential for Alleviating Diabetes and Its Complications
por: Palmer, Allyson K, et al.
Publicado: (2021)

Characteristics of Focal Gamma Zone Parapapillary Atrophy
por: Kim, Hae Rang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7s40p771b7ptcleuuc3tkdvcah